Sandra Palus, Yulia Elkina, Tanja Braun, Stephan vonHaehling, Wolfram Döhner, Stefan D. Anker, . . . Jochen Springer. (2022). The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia. Wiley.
Chicago Style (17th ed.) CitationSandra Palus, Yulia Elkina, Tanja Braun, Stephan vonHaehling, Wolfram Döhner, Stefan D. Anker, Anthony Cerami, Michael Brines, and Jochen Springer. The Erythropoietin‐derived Peptide ARA 284 Reduces Tissue Wasting and Improves Survival in a Rat Model of Cancer Cachexia. Wiley, 2022.
MLA (9th ed.) CitationSandra Palus, et al. The Erythropoietin‐derived Peptide ARA 284 Reduces Tissue Wasting and Improves Survival in a Rat Model of Cancer Cachexia. Wiley, 2022.
Warning: These citations may not always be 100% accurate.